IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Zosano Pharma Corp. & Advises Investors With Losses in...
August 26 2016 - 9:54PM
Business Wire
Lundin Law PC (http://lundinlawpc.com/) announces it is
investigating claims against Zosano Pharma Corporation (“Zosano” or
the “Company”) (Nasdaq: ZSAN) concerning possible violations of
federal securities laws.
To get more information about this investigation, please contact
Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via
email at brian@lundinlawpc.com.
No class has been certified in the above action. Until a class
is certified, you are not considered represented by an attorney.
You may also choose to do nothing and be an absent class
member.
The investigation concerns whether the Company violated Sections
10(b) and 20(a) of the Securities Exchange Act of 1934.
Specifically, the investigation will focus on whether the Company's
filings with the SEC concerning its January 2015 Initial Public
Offering were misleading. The Company offered more than 6,500,000
shares of its common stock at $11.00 per share in connection with
its IPO.
Lundin Law PC was founded by Brian Lundin, a securities
litigator based in Los Angeles dedicated to upholding shareholders’
rights.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160826005848/en/
Lundin Law PCBrian Lundin, Esq.Telephone: 888-713-1033Facsimile:
888-713-1125brian@lundinlawpc.comhttp://lundinlawpc.com/
Zosano Pharma (NASDAQ:ZSAN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Zosano Pharma (NASDAQ:ZSAN)
Historical Stock Chart
From Apr 2023 to Apr 2024